The project to create scientific and educational units Tashkent pharma park is being implemented

Resolution of the Cabinet of Ministers No. 152 of April 4, 2022 "On measures to implement the project" Creation of scientific and educational parts of the innovative research and production pharmaceutical cluster "Tashkent Pharma Park" (Phase I).

In accordance with the Presidential Decree No. PQ-4574 dated January 28, 2020, an innovative research and production pharmaceutical cluster "Tashkent Pharma Park" was established in Zangiota district of Tashkent region.

The cluster includes a pharmaceutical technical university with its own infrastructure, including research centers and laboratories, a pharmacopoeia center and a hotel symposium center, as well as an industrial zone for the production of innovative drugs, medical devices and medical equipment.

The project will be implemented in two phases with the phased financing and implementation of construction and installation work.

In the first stage, the construction of educational buildings of the multidisciplinary university, educational and scientific laboratories, a center for pre-clinical research, a pharmacopoeia center, a library, a sports and health complex, and housing will be carried out.

The Economic Development and Cooperation Fund (EDCF) of the Eximbank of Korea of ​​the Government of the Republic of Korea has provided a loan to the Republic of Uzbekistan in the amount of USD 83.7 million for a period of 40 years with a grace period of 10 years.

A TIA worth $ 98.6 million has been developed for the project. The Pharmaceutical Industry Development Agency is the executive body responsible for implementing the project.